Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
Hims & Hers shares drop after Novo Nordisk ends Wegovy collaboration over compounding practices
11:50am, Monday, 23'rd Jun 2025
Shares of Hims & Hers Health (NYSE:HIMS) fell around 30% on Monday after Novo Nordisk (NYSE:NVO) terminated its collaboration with the telehealth company, citing violations related to compounding and
Novo Nordisk under pressure, ends deal with Hims & Hers
11:44am, Monday, 23'rd Jun 2025
CNBC's Angelica Peebles joins 'Squawk on the Street' with the latest details on the pharmaceutical space.
S&P 500 (NYSEARCA: SPY) Live: Markets Turn Higher in Face of Heightened Mideast Tensions
11:00am, Monday, 23'rd Jun 2025
Live Updates Live Coverage Updates appear automatically as they are published. Interest Rate Tailwind 10:30 am by Gerelyn Terzo In a week heavy with Fed speakers making the rounds, Federal Reserve Gov
Live Nasdaq Composite: Markets Hold Steady, Oil Price Soars Amid Mideast Escalation
11:00am, Monday, 23'rd Jun 2025
Live Updates Live Coverage Updates appear automatically as they are published. Oil Price 10:00 am by Gerelyn Terzo President Trump in a post on Truth Social has urged the world to keep oil prices lowe
Novo Nordisk, Hims and Hers Shares Tumble on Severed Ties
10:55am, Monday, 23'rd Jun 2025
Novo Nordisk A/S (NYSE:NVO) stock is down 5.3% to trade at $69.90 at last check, after the drugmaker's obesity drug CagriSema showed no clear advantage over Eli Lilly's (LLY) Zepbound.
BOSTON, June 23, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Hims & Hers Health, Inc. (NYSE: HIMS) for potential securities law violations. Investors who have lost money in their Hims &
HIMS Plummets, AMD Upgrade, DASH 3-Year High
10:21am, Monday, 23'rd Jun 2025
Diane King Hall joins Nicole Petallides at the NYSE to focus on several early movers in Monday's trading session. Hims & Hers (HIMS) shares drop on news that Novo Nordisk (NVO) will no longer allow th
Hims & Hers' stock plunges. Here's why Wegovy parent ended its partnership with the company.
10:05am, Monday, 23'rd Jun 2025
Hims & Hers Health Inc.'s stock fell sharply on Monday after pharmaceutical giant Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration with the telehealth-consultatio
HIMS stock plunges as Novo Nordisk severs ties with Hims & Hers over Wegovy sales
09:52am, Monday, 23'rd Jun 2025
Novo Nordisk A/S has abruptly terminated its partnership with Hims & Hers Health Inc., just weeks after it was announced, over concerns related to the telehealth company's sale and promotion of compou
Hims & Hers stock crashes over 20% on Wegovy shocker
08:56am, Monday, 23'rd Jun 2025
Hims & Hers Health (NYSE: HIMS) stock has plunged sharply after Novo Nordisk (NYSE: NVO) announced it was severing ties with the telehealth firm over concerns about the distribution of its weight loss
Hims & Hers Stock Plunges as Novo Nordisk Abruptly Ends Partnership
08:36am, Monday, 23'rd Jun 2025
Novo Nordisk accuses the telehealth company of breaking a law related to drug compounding.
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
08:20am, Monday, 23'rd Jun 2025
Novo Nordisk said it is ending its collaboration with Hims & Hers due to concerns about the telehealth company's sales and promotion of cheaper knock-offs of the weight loss drug Wegovy. Novo Nordis
Collaboration of over one month has ended based on Hims & Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy ® that put patient safety at risk Novo Nordisk won't stop
Novo Nordisk ends collaboration with Hims & Hers over weight loss drug sale
07:46am, Monday, 23'rd Jun 2025
Novo Nordisk said on Monday it would halt its collaboration with Hims & Hers Health over the sale of weight loss drugs.
3 Stocks to 3X in 3 Years
10:31am, Sunday, 22'nd Jun 2025
Key Points in This Article: Long-term investing over three to five years — or ideally decades — leverages compounding returns to build wealth, outperforming short-term trading's volatility and fre
